J. C. Gallagher, MD
J. C. Gallagher, MD

J. C. Gallagher, MD

Professor
School of Medicine

Academic Appointments

Department

  • Medicine

Position

  • Professor

Education

  • Manchester University,M.B., Ch.B.,to 1965
  • Leeds University Hospital,M.R.C.P.,to 1970
  • Manchester University,M.D.,to 1976

Publications and Presentations

Books

  • Gallagher JC.Effect of Estrogen on Bone in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism.American Society Bone & Mineral Research 2003.Cadmuus press, Not Applicable, Fifth Edition, 327-330, 2003
  • Gallagher JC. Osteoporosis. In: Conn's Current Therapy. Eds: R Rakel. WB Saunders. Philadelphia 1999, Not Applicable, 1999

Articles

  • Palacios S, Kalouche-Khalil L, Rizzoli R, Zapalowski C, Resc H, Adachi JD, Gallagher JC, Feldman RG, Kendler DL, Wang A, Wagman RB, Adami S. Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis. Climacteric. 2015 Jun 1:1-23., Climacteric, 2015;18(6), 805-12, 2015
  • Gallagher JC. Bone mineral density measurements: how often should bone mineral density be measured in postmenopausal women? Results from the Women's Health Initiative study. Menopause. 2015 Jun;22(6):581-3., Menopause, 2015 Jun;22(6), 581-3, 2015
  • Labrie F, Archer DF, Bouchard C, Girard G, Ayotte N, Gallagher JC, Cusan L, Baron M, Blouin F, Waldbaum AS, Koltun W, Portman DJ, Côté I, Lavoie L, Beauregard A, Labrie C, Martel C, Balser J, Moyneur É; Members of the VVA Prasterone Group. Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study. Maturitas. 2015 May;81(1):46-56, Maturitas, 2015 May;81(1), 46-56, 2015
  • Tella SH, Gallagher JC. Efficacy of desvenlafaxine succinate for menopausal hot flashes. Expert Opin Pharmacother. 2014 Nov;15(16):2407-18., Expert Opin Pharmacother, 2014 Nov;15(16), 2407-18, 2014
  • Tella SH, Gallagher JC. Biological agents in management of osteoporosis. Eur J Clin Pharmacol. 2014 Nov;70(11):1291-301., European Journal of Clinical Pharmacology, 2014 Nov;70(11), 1291-301., 2014
  • Gallagher JC, Smith LM, Yalamanchili V. Incidence of hypercalciuria and hypercalcemia during vitamin D and calcium supplementation in older women. Menopause. 2014 Nov:21(11):1173-80., Menopause, Nov:21(11), 1173-80, 2014
  • Kaufmann M, Gallagher JC, Peacock M, Schlingmann KP, Konrad M, DeLuca HF, Sigueiro R, Lopez B, Mourino A, Maestro M, St-Arnaud R, Finkelstein JS, Cooper DP, Jones G. Clinical Utility of Simultaneous Quantitation of 25-Hydroxyvitamin D and 24,25-Dihydroxyvitamin D by LC-MS/MS Involving Derivatization With DMEQ-TAD. J Clin Endocrinol Metab. 2014 Jul;99(7):2567-74, Journal of Clinical Endocrinology and Metabolism, 2014 Jul;99(7), 2567-74, 2014
  • Gallagher JC, Jindal PS, Smith LM. Vitamin d does not increase calcium absorption in young women: a randomized clinical trial.J Bone Miner Res. 2014 May;29(5):1081-7, J Bone Miner Res, 2014 May;29(5), 1081-7, 2014
  • Gallagher JC, Tella SH. Controversies in osteoporosis management: antiresorptive therapy for preventing bone loss: when to use one or two antiresorptive agents?. Clin Obstet Gynecol. 2013 Dec;56(4):749-56., Clinical Obstetrics and Gynecology, 2013 Dec;56(4), 749-56, 2013
  • Tella SH, Gallagher JC. Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause. Expert Opin Pharmacother. 2013 Dec;14(17):2407-20, Expert Opin Pharmacother, 2013 Dec;14(17), 2407-20, 2013
  • Tella SH, Gallagher JC. Prevention and treatment of postmenopausal osteoporosis.J Steroid Biochem Mol Biol. 2013 Oct 29. pii: S0960-0760(13)00182-9, Journal of Steroid Biochemistry and Molecular Biology, S0960-0760(13), 182-9, 2013
  • Gallagher JC. The effects of calcitriol on falls, fractures and physical performance tests., Journal of Steroid Biochemistry and Molecular Biology, 89-90, 498-501, 2004
  • Effect of vitamin D2 supplement use on serum concentrations of 25OHD levels in elderly women., Journal of Steroid Biochemistry and Molecular Biology, 89-90, 601-604, 2004
  • Rapuri PB, Gallagher JC, Knezetic JA, Kinyamu HK, Ryschon KL. Association between vitamin D receptor polymorphism and the rate of bone loss in postmenopausal elderly women. Importance of adjusting for dietary and lifestyle factors., Journal of Steroid Biochemistry and Molecular Biology, 89-90, 500-506, 2004
  • 172. Gallagher JC, Satpathy R, Rafferty K, Haynatzka V. The Effect of Soy Protein Isolate on Bone Metabolism, Menopause, 11,no3, 290-298, 2004
  • Effect of vitamin D2 and D3 supplement use on serum 25OHD concentration in elderly women in summer and winter, Calcif Tissue Int, 74, 150-156, 2004
  • Lindsay R, Gallagher JC, Kleerekoper M, Pickar JH. The Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women., J.A.M.A., 287(20), 2668-76, 2002
  • Rapuri PB, Kinyamu HK, Gallagher JC, Haynatzka V. Seasonal changes in calciotropic hormones, bone markers, and bone mineral density in elderly women., J Clin Endocrinol Metab, 87(5), 2024-32, 2002
  • Rapuri PB, Gallagher JC, Kinyamu HK, Ryschon KL. Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes., American Journal of Clnical Nutrition, 74(5), 694-700, 2001
  • Gallagher JC, Baylink DJ, Freeman R, McClung M. Prevention of Bone Loss with Tibolone in Postmenopausal Women: Results of Two Randomized, Double blind, Placebo controlled, Dose-Finding Studies., Journal of Clinical Endocrinology and Metabolism, 86 (10), 4717-4726, 2001
  • Heaney, RP, Gallagher JC, Dawson Hughes E, Marcus R, Nieves J. The Role of Calcium in Peri-and postmenopausal women., Menopause, 8(2), 84-95, 2001
  • Gallagher, JC, Fowler S, Sherman SS. Combination treatment with Estrogen and Calcitriol in the prevention of Age-Related Bone Loss., J Clin Endocrinol Metab, 18 (8), 3618-3628, 2001
  • Speroff L, Gallagher JC, Pinkerton J, Raisz L, Montgomery Rice V. The impact of low-dose HRT., Contemporary ObGyn, Supplement Issue, 4-25, 2001
  • Gallagher JC. Meeting the bean half way, Menopause, 8(3), 152-3, 2001
  • Gallagher JC, Fowler S, Sherman SS. Combination treatment with estrogen and calcitriol in the prevention of age related bone loss, J. Clin Endo. and Metab., 86, 3618-3628, 2001
  • Rapuri PB, Gallagher JC, Balhorn KE, Ryschon KL. Alcohol Intake and Bone metabolism in elderly women, American Journal of Clnical Nutrition, 72, 1206-1213, 2000
  • Rapuri PB, Gallagher JC, Balhorn KE, Ryschon KL. Smoking & Bone Metabolism in Elderly Women, Bone, 27, 429-436, 2000
  • Gallagher JC. The role of estrogen in the prevention of osteoporosis, Rheumatic Disease Clinics of North America, 27(1), 84-95, 2000
  • Gallagher JC. Moderation of the daily dose of HRT: prevention of osteoporosis. Maturitas 33 (1999) S57-S63 Schneider HPG, Gallagher JC Moderation of the daily dose of HRT: benefits for patients Maturitas 33 (1999) S25-29, Not Applicable, 1999
  • Rapuri PB, Kinyamu HK, Gallagher JC, Haynatzka V. Seasonal changes in calciotropic hormones, bone markers, and bone mineral density in elderly women. J Clin Endocrinol Metab. 2002 May;87(5):2024-32.
  • Lindsay R, Gallagher JC, Kleerekopper M, Pickar JH. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women. JAMA. 2002 May 22-29; 287(20):2668-76
  • Gallagher JC Rapuri PB, Haynatzka G, Detter JR Effect of Discontinuation of Estrogen, Calcitriol and the Combination of both on Bone Density and Bone Markers J Clin Endocrinol Metab 2002 (Nov) 87:4914-4923,2002
  • Gallagher JC. Tibolone is effective in preventing postmenopausal bone loss. In Women’s Health and Menopause. Ed. Lobo RA, Crosignani PG, Paoletti R, Bruschi F. Kluwer-Boston 2002
  • Rapuri PB, Gallagher JC, Haynatzka V. Protein Intake- Effect on Bone Mineral Density and the Rate of Bone Loss in elderly Women Am J Clin Nutr 2003(June)77:1517-1525
  • Gallagher JC, Rapuri PB. Osteoporosis: Pathophysiology. in Encyclopedia of Hormones. Academic Press New York 2003
  • Rapuri PB, Gallagher JC, Balhorn KE, Ryschon KL. Alcohol Intake and Bone metabolism in Elderly Women. Am J Clin Nutr.72: 1206-1213,2000 Nov
  • Santoro N. Altman A, Archer D, Gallagher JC. The promise of HRT. Contemp Ob.Gyn June 4-25, 2000
  • Consensus Opinion. The Role of Calcium in Peri- and postmenopausal women.Menopause.8, (2), 84-95, 2001
  • Gallagher JC. The role of Estrogen in the prevention of Osteoporosis in Rheumatic Disease Clinics of North America .27,(1),84-95,2001
  • Speroff L ,Gallagher JC, Pinkerton J, Raisz L ,Montgomery Rice V, The Impact of low dose HRT Contemporary ObGyn.2001
  • Gallagher JC, Fowler S, Sherman SS. Combination treatment with Estrogen and Calcitriol in the prevention of Age-Related Bone Loss. J.Clin.Endocrinol.Metab 86:3618- 3628, 2001.
  • Rapuri PB, Gallagher JC, Kinyamu HK, Ryschon KL. Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes. Am J Clin Nutr. 2001 Nov;74(5):694-700.
  • Gallagher JC, Baylink DJ, Freeman R, McClung M. Prevention of Bone Loss with Tibolone in Postmenopausal Women: Results of Two Randomized, Double blind, Placebo controlled, Dose-Finding Studies. J. Clin Endocrinol Metab. 86(10): 4717-4726, 2001 Oct
  • Rapuri PB, Gallagher JC, Balhorn KE, Ryschon KL. Smoking and Bone Metabolism in Elderly women. Bone 27:429-436,2000 Sep

Publications

  • Gallagher JC. Letter to the editor. Menopause. 2015 May;22(5):579., Menopause, 2015 May;22(5), 579, 2015
  • Rapuri PB, Gallagher, JC, Knezetic JA, Ryschon, KL. PTH Genotypes and Rate of Bone Loss-Response to Treatment with Estrogen and the Calcitriol in Postmenopausal Woemn. J Bone Min Res, Not Applicable, 2001
  • Rapuri PB, Gallagher JC, Knezetic JA. Influence of Calcium Intake on the Interaction of Vitamin D Receptor Genotypes and the Rate of Bone Loss in Elderly Woemn. J Bone Min Res, Not Applicable, 2001
  • Rapuri PB, Gallagher JC, Ryschon KL. Protein intake-Effect om BMD and the rate of bone loss in elderly women. J BOne Min Res, Not Applicable, 2001
  • Gallagher, JC, Greenwald M, Wasnich R, Symons J. Dose -related Increases in Bone Mineral Density due to Norethindrone Acetate in Postmenopausal Women Treated with Ethinyl Estradiol. J Bone Min Res, Not Applicable, 2001
  • Gallagher, JC, Rapuri PB, Haynatski G, Detter JR. Effect of Discontinuation of Estrogen, Calcitriol, and the Combination of Estrogen and Calcitriol on Bone Mineral Density and Bone Markers. J Bone Min Res, Not Applicable, 2001
  • Gallagher JC, Greenwald M, Wasnich R, Symons J. Dose related increases in bone mineral density due to norethindrone acetate in postmenopausal women treated with ethinyl estradiol, J. Bone Miner. Res., 2001
  • Rapuri PB, Gallagher JC, Ryschon KL. Protein Intake-Effect of BMD and the rate of bone loss in elderly women, Journal of Bone Mineral Research, 2001
  • Lindsay R, Gallagher JC, Kleerekoper M, Pickar JH. Impact of adding medroxyprogesterone acetate (MPA) to multiple doses of conjugated equine estrogens (CEE) on bone density in postmenopausal women, J. Bone Miner. Res., 2001
  • Rapuri PB, Gallagher JC, Knezetic JA. Influence of Calcium Intake on the interaction of vitamin D receptor genotypes and the rate or bone loss in elderly women, J. Bone Miner. Res., 2001
  • Rapuri PB, Galagher JC, Knezetic J, Kimyamu HK. High caffeine intake increases the rate of bone loss in elderly women with VDR genotype tt, Not Applicable, 2000
  • Rapuri PB, Gallagher JC, Knezetic J, Kimyamu HK. Vitamin D receptor genotypes are associated with different responses in BMD to estrogen and calcitriol in elderly women, Not Applicable, 2000
  • Rapuri PB, Gallagher JC, Knezetic J, Kinyamu HK. Association between bone loss and VDR polymorphism. Importance of environmental life style factors, J. Bone Miner. Res., 15(S1), 364, 2000
  • Rapuri PB, Gallagher JC, Knezetic JA, Kinyamu HK. The association between bone loss and vitamin D receptor polymorphism and bone loss in elderly women, J. Bone Miner. Res., 15(S1), 263, 2000
  • PTHrP(1-34)Analog, Semparatide Acetate (RS-66172), Causes sustained increased in spine in postmenopausal osteoporotic women. Two Randomized placebo-controlled trials. Gallagher JC, Semparatide investigators. ASBMR J Bone & Min Res 1018:S137,1999, Not Applicable, 1999
  • Tibolone prevents postmenopausal bone loss and is well tolerated: phase III trial results. Gallagher JC, Freeman R, Baylink DK etal. ASBMR J Bone & Min Res 1104:S158,1999, Not Applicable, 1999
  • The relationship between bone mineral density and bone markers in elderly women: a longitudinal study. Balhorn KE, Thiyyari PP, Bloes K, Gallagher JC. ASBMR J Bone & Min Res F200:S250, 1999, Not Applicable, 1999
  • Effect of alcohol on bone density in elderly women. Thiyyari P, Balhorn KE, Pease A, Gallagher JC. ASBMR J Bone & Min Res F320:S273, 1999, Not Applicable, 1999
  • Effect of smoking on intestinal calcium absorption and bone mineral density in elderly women. Thiyyari P, Balhorn KE, Pease A, Gallagher JC. ASBMR J Bone & Min Res SA324:S389, 1999, Not Applicable, 1999
  • Effect of HRT and/or Calcitriol therapy and its discontinuation on calcium absorption and bone markers in elderly women. Balhorn KE, Thiyyari PP, Gallagher JC. ASBMR J Bone & Min Res SA403:S410, 1999, Not Applicable, 1999
  • Effect of estrogen, calcitriol and a combination of estrogen and calcitriol on bone mineral density and fractures in elderly women. Gallagher JC, Fowler S. ASBMR J Bone & Min Res T364:S209, Not Applicable, 1999
  • Abstracts 2001 Rapuri PB, Gallagher JC, Knetezic J, Kinyamu HK .The association between Bone loss and Vitamin D receptor polymorphism and bone loss in elderly women J Bone Min Res 15(S1), 263, 2000. Rapuri PB, Gallagher JC, Knetezic J, Kinyamu HK. Vitamin D receptor genotypes are associated with different responses in BMD to estrogen and calcitriol in Elderly Women .J Bone Min Res 15(S1), 361, 2000. Rapuri PB, Gallagher JC, Knezetic J and Kinyamu HK. High caffeine intake increases the rate of bone loss in elderly women with VDR genotype tt. J Bone Min Res. 15(S1), 535, 2000. Rapuri PB, Gallagher JC, Knezetic JA, Kinyamu HK. Association between bone loss and VDR polymorphism. Importance of Environmental and Life style factors.J Bone Min Res.15 (S1), 364, 2000.
  • Abstracts 2002 154 Rapuri PB, Gallagher JC, Haynatzki G. Endogenous Levels of Estrogen Determine the Response to Treatment with Hormone Replacement Therapy in Elderly Women. J Bone &Min Res 17(S1),358,2002 155 Gallagher JC, G. Haynatzki G, Fowler s. Effect of Estrogen, Calcitriol or the Combination of Both on Falls and Non Vertebral Fractures in Elderly Women J Bone &Min Res 17(S1),381,2002 156 Lindsay R, Gallagher JC, Kleerekopper M, Northington R, Qi K, Pickar J. Influence of BMI on changes in BMD with multiple doses of conjugated equine estrogens and medroxyprogesterone acetate in early postmenopausal women. J Bone &Min Res17(S1),482, 2002 157 Rapuri PB, J. C. Gallagher JC, Haynatzka V. Vitamin A Intake and Bone Mineral Density Postmenopausal Women. J Bone &Min Res17(S1),285 2002 157 Rapuri PB, Gallagher JC, Haynatzki G. Low Levels of Serum Estradiol contribute to the Rate of Bone Loss in Postmenopausal Elderly Women J Bone &Min Res 17(S1), 163, 2002
  • Abstracts 2003 Rapuri, PB, Gallagher, JC, Haynatzki, G. Response to Treatment with Estrogen is Related to Endogenous Levels of Testosterone and SHBG. J Bone & Min Res 18(S1),2003 149 Rapuri, PB, Gallagher, JC, Haynatzki, G. Serum Total and Bioavailable Testosterone Levels are Associated with Lower BMD in Elderly Women. J Bone & Min Res 18(S1), 2003 150 Rapuri, PB, Gallagher, JC, Haynatzka, V. No Effect of Estrogen Receptor Gene Polymorphisms on Bone Mineral Density, Bone Loss and Treatment Response to Estrogen. J Bone & Min Res 18(S1), 2003 161 Gallagher JC, Satpathy R, Rapuri PB. Effect of Calcitriol on Serum and Urine Calcium. J Bone & Min Res 18(S1), 2003 162 P.B. Rapuri, J.C. Gallagher, G. Haynatzki. .Endogenous Levels of Testosterone and SHBG are Related to BMD. Rate of Bone Loss and Response to Treatment with Estrogen in Elderly Women. Menopause 2003.

Presentations

  • Gallagher J, Yousefian S, Smith L. Falls are increased on recommended doses of vitamin D in elderly women. Presented at the ASBMR, Seattle, WA, October 11, 2015, 2015
  • Gallagher J. Meet-the-Professor Session: Calcium and Vitamin D: Current Status. Oral presentation at the ASBMR, Seattle, WA, October 9-12, 2015., 2015
  • 2015 June. China. 5 regional Endocrinology lectures on Vitamin D and/or analogs –Xi’an, Changsa, Hangzhou, Harbin, Shanghai, 2015
  • 2015 June. Montreal International Nutrition Society. ‘Is there a threshold for vitamin D’?, 2015
  • 2015 May. Brazilian Society Endocrinology. Role of Calcium and vitamin D in Osteoporosis., 2015
  • Creighton University presentations Endocrine fellows: 2015/4 ‘long term problems with bisphosphonates’, 2015
  • 2015 April. Colombian Society Endocrinology Bisphosphonates –long term complications. The year in osteoporosis-2014 ( magisterial lecture)., 2015
  • Endocrine Society posters/oral March 2015 Effect of vitamin D on depression( Poster). March 2015 Incidence of Hypercalciuria and Hypercalcemia during Vitamin D and Calcium Supplementation in Older and Younger Women: A Comparison Between Caucasians and African Americans in Two Randomized Trials (ORAL). March 2015 Chronic Functional Hypoparathyroidism due to Magnesium Deficiency.(Poster prize) March2015 The effect of Vitamin D supplementation on Falls and physical performance in elderly A randomized clinical trial (Poster)., 2015
  • Creighton University presentations Endocrine fellows: 2014/December GRAND rounds. ‘Hormone Therapy for postmenopausal women New Perspectives’, 2014
  • 2014/December NIH –NIA-ODS Meeting ‘Effect of vitamin D’, 2014
  • Creighton University presentations Endocrine fellows: 2014 November ‘Hypocalcemia’,, 2014
  • American Society Bone & Mineral Research ASBMR. 2014/October : No significant change in Bone mineral density after vitamin D supplementation in young and elderly women (Poster)., 2014
  • North American Menopause Society Dallas.2014/9 ‘ The RDA for vitamin D’., 2014
  • 2014/August .American Society Clinical Endocrinologists. Hormone therapy for Post Menopausal women. New Perspectives., 2014
  • Creighton University presentations Endocrine fellows: 2014/August ‘Hypercalcemia’ 8/201411/2014, 2014
  • Endocrine Society posters/oral June 2014 Effect of Vitamin D Supplementation on BMD in Young and Elderly Women (Poster), 2014
  • Management of osteoporosis, 2003
  • Anti resorptives in osteoporosis, 2003
  • Hormone use in postmenopausal women.Risk benefit, 2003
  • Vitamin D analogs reduce falls, 2003
  • Hormone use in postmenopausal women, 2003
  • Hormone use in postmenopausal women, 2003
  • Hormone use in postmenopausal women, 2003
  • Vitamin D analogs in osteoporosis, 2003
  • Use of HT/ET in postmenopausal women, 2003
  • Preventing bone loss in postmenopausal women with hormones, 2003
  • Management of Osteoporosis, 2003
  • Effects of calcitriol on falls and fractures in postmenopausal women, 2003
  • Treatment of Osteoporosis, 2002
  • Effect of Vitamin D analogs on Falls and fractures, 2002
  • Synergistic Effects of Progestins and Estrogen on Bone, 2002
  • Combination Therapy in Osteoporosis, 2002
  • Vitamin D analogs reduce Falls and Fractures, 2002
  • HRT use in postmenopausal women, 2002
  • The effect of low dose estrogen on Bone, 2002
  • Preventing early postmenopausal bone loss, 2002
  • Prevention of early post menopausal bone loss, 2002
  • Effect of Progestins on Bone, 2002
  • Tibolone for preventing osteoporosis, 2002
  • Preventing Early Postmenpausal Bone Loss, 2002
  • Preventing Early Postmenopausal Bone Loss, 2002
  • Prevention of Falls and Fractures in the Elderly, 2002
  • The importance of preventing Early Post Menopausal Bone losss, 2002
  • Low dose estrogen use in the Menopause, 2002
  • The use of low dose estrogen in prevention of Osteoporosis, 2002
  • Prevention of Falls with Vitamin D Compounds, 2002
  • Management of post menopausal osteoporosis, 2002
  • The Effects of Progestins on Bone, 2001
  • Effects of Tibolone on Bone, 2001
  • Management OF Osteoporosis, 2001
  • Osteoporosis- Diagnosis and Management, 2001
  • Endocrine Society. 2 presentations. Effect of Low dose HRT therapy on bone. Effects of Tibolone on bone,lipids and coagulation, 2001
  • American Society Clinical Endocrinology. Low dose estrogen therapy prevents bone loss, 2001
  • South American Menopause society.3 lectures. Treatment of osteoporosis with parathyroid hormone. Low dose estrogen therapy -metabolic effects on lipids and bone. Combinarion therapy in osteoporosis., 2001
  • Grand rounds-University nebraska medical center. Hormone replacement therapy inprevention of bone loss, 2001
  • Clarkson Family practice.treatment oof osteoporosis, 2001
  • Clarkson Family practice.treatment oof osteoporosis, 2001
  • Mexican Osteoporosis Society.Combination Treatment of Osteoporosis, 2001
  • North American Menopause Society. diagnosis of Osteoporosis, 2000
  • Vietnamese Osteoporosis Society Therapy for Osteoporosis-update, 2000
  • Malaysian Osteoporosis Society. Combination therapy in Osteoporosis, 2000
  • Febr 99-Research Mtg on Osteoporosis, Diabets & Lipids-Update on Osteoporosis, 1999
  • Australia Practice Meeting in Brisbane-Treatment of Osteoporosis, 1999
  • March 1999-Women's Health 2000 in Porto Alegue Brazil-1. Diagnosis of Osteoporosis 2. Treatment of Osteoporosis, 1999
  • May 1999-10th World Congress on Women's Health & Reproduction-HRT Treatment After Menopause, 1999
  • Venezuela Menopause Society in Caracas, Venezuela-Combination Therapy in Osteoporosis, 1999
  • Confronting Aging & Diseases in Atlanta Georgia-Annual PA's Meeting, 1999
  • June 1999-NIH Workshop in Phoenix AZ-Role of Phytoestrogens on Bone Metabolism, 1999
  • Annual Meeting Hungarian Menopause Society in Budapest, Hungary-Use of HRT in Postmenopausal Women, 1999
  • Oct 1999-28th Brazilian Congress of Radiology in Sao Paolo Brazil-1. Value of Densitometry in Practice 2. Diagnosis of Osteoporosis, 1999
  • Oct 1999-9th International Menopause Society-Combination Treatment in Osteoporosis, 1999
  • Oct 1999-Annual Meeting Thai Society of Ob/Gyn-HRT Treatment in the Elderly, 1999
  • Nov 1999-3rd International Meeting on the Role of Soy-Effect of Soy on Bone, 1999
  • Nov 99-48th Congress of Brazilian Ob/Gyn-1. SERMS in the Prevention of osteoporosis, 2. Use of HRT or ERT in the Elderly, 3. Osteoporosis. Prevention & Treatment., 1999
  • September 99-ASBMR-5 abstracts 2 presentations, 1999